Inocras, AimedBio team up for cancer treatments
Combining whole genome data with AimedBio’s drug development approach is expected to speed up clinical development.
Drug Development
US FDA rejects approval of Unicycive’s kidney disease therapy
Beyond the GLP-1RA weight loss ceiling
Eli Lilly and Innovent agree Verzenios commercialisation deal in China
Anixa Biosciences secures Korean patent for breast cancer vaccine
Zymeworks agrees to buy Theravance Biopharma for $929m
FDA issues complete response letter to Sobi’s NASP for gout
Lilly’s Jaypirca receives CHMP positive opinion for CLL in Europe
